评估间歇性跛行管理在血管外科学会适用标准发布前后的变化
该研究基于血管质量倡议(VQI)注册数据库,比较了2022年4月血管外科学会(SVS)发布间歇性跛行(IC)适用标准(AUC)前后,外周血管介入(PVI)和旁路手术的管理模式变化。共分析15,892例PVI、2,352例腹股沟上旁路和3,480例腹股沟下旁路手术。结果显示,严重症状干预比例、术后最佳药物治疗(OMT)使用率提高,透析患者PVI和复杂(TASC II C/D)主髂及股腘病变干预减少;但充血性心力衰竭患者PVI、股总动脉(CFA)PVI及孤立膝下病变PVI反而增加。
要点
- AUC发布后,严重症状患者接受PVI的比例从66.6%升至72%(P < .001)。
- 术后OMT使用率从79.7%升至83%(P < .001),透析患者PVI比例从2.7%降至2%(P < .002)。
- 复杂TASC II C/D主髂病变PVI从9.5%降至6.3%,股腘病变从5.8%降至4.5%(均P < .001)。
核心结论
- AUC发布后,术后OMT改善、终末期肾病患者干预减少、复杂病变腔内治疗减少。
- 但充血性心力衰竭患者PVI、CFA和孤立膝下病变PVI反而增加,与适用标准不一致。
- 作者认为仍需进一步努力改善术前医疗优化,并减少CFA、膝下病变腔内干预、解剖外主髂血运重建及人工血管旁路的使用。
研究设计与样本
- 分析血管质量倡议(VQI)外周血管介入(PVI)及腹股沟上和腹股沟下旁路注册数据,纳入间歇性跛行干预患者。
- 比较AUC发布前(2018-2019年)与发布后(2022年5月至2023年12月)的患者和干预特征。
- 共分析15,892例PVI、2,352例腹股沟上旁路和3,480例腹股沟下旁路手术。
主要发现
- 严重症状干预比例AUC前66.6% vs 后72%(P < .001)。
- 术后OMT使用率AUC前79.7% vs 后83%(P < .001)。
- 透析患者PVI比例AUC前2.7% vs 后2%(P < .002)。
- 复杂TASC II C/D主髂病变PVI比例AUC前9.5% vs 后6.3%(P < .001),股腘病变PVI比例AUC前5.8% vs 后4.5%(P < .001)。
- 充血性心力衰竭患者PVI比例AUC前12.8% vs 后15.1%(P < .001);CFA PVI比例AUC前3.4% vs 后5.2%(P < .001);孤立膝下病变PVI比例AUC前3.5% vs 后5.7%(P < .001)。
关键数值与推荐
- 术前吸烟率、术前OMT使用率、80岁以上患者干预率、解剖外腹股沟上旁路、膝下旁路及人工血管使用率均无变化。
临床怎么用
- AUC发布后,严重症状患者干预比例增加、术后OMT改善、透析患者PVI减少、复杂主髂及股腘病变PVI减少。
- 充血性心力衰竭患者PVI、CFA PVI及孤立膝下病变PVI增加,与适用标准不一致。
- 作者认为需进一步改善术前医疗优化,并减少CFA和膝下病变腔内干预、解剖外主髂血运重建及人工血管旁路使用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In April 2022, the Society for Vascular Surgery (SVS) published the Appropriate Use Criteria (AUC) for the management of intermittent claudication (IC). Our goal was to compare practice patterns before and after publication of the AUC to identify changes. METHODS: The Vascular Quality Initiative (VQI) peripheral vascular intervention (PVI) and suprainguinal and infrainguinal bypass registries were analyzed for interventions for IC. Relevant patient and intervention characteristics pre-AUC (2018-2019) and post-AUC (May 2022-December 2023) were compared. Key points of the AUC that are analyzable from the VQI include claudication severity, use of optimal medical therapy (OMT), smoking status, high-risk comorbid conditions (as indicators of operative risk), operative management of complex aortoiliac and femoropopliteal disease (TASC II C/D), common femoral artery (CFA) PVIs, and infrapopliteal procedures. RESULTS: There were 15,892 PVI, 2352 suprainguinal bypass, and 3480 infrainguinal bypass procedures analyzed. Changes consistent with the appropriateness ratings for PVI included more interventions for severe symptoms (72% vs 66.6%; P < .001), improvement in postoperative OMT (83% vs 79.7%; P < .001), fewer patients on dialysis undergoing PVI (2% vs 2.7%; P < .002), and less interventions on complex (TASC II C/D) aortoiliac (6.3% vs 9.5%; P < .001) and femoropopliteal (4.5% vs 5.8%; P < .001) anatomy. No changes were seen in the rates of preoperative smoking and preoperative OMT use, interventions on octogenarians, or in the use of extra-anatomic suprainguinal bypass, infrapopliteal bypass, or prosthetic conduit. Inconsistent with appropriateness ratings were more patients with congestive heart failure (15.1% vs 12.8%; P < .001) undergoing PVIs, and more PVIs for CFA (5.2% vs 3.4%; P < .001) and isolated infrapopliteal disease (5.7% vs 3.5%; P < .001). CONCLUSIONS: Since the publication of the AUC, there have been improvements with better OMT on discharge, fewer patients with end-stage renal disease undergoing interventions, and less endovascular treatment of complex disease. However, further work is needed to improve preoperative medical optimization in patients with IC undergoing an invasive intervention and decrease the use of endovascular interventions for CFA and infrapopliteal disease, extra-anatomic aortoiliac revascularizations, and prosthetic conduit use.
引用
- Alonso A, Kobzeva-Herzog A, Dalton-Petillo S, et al. Evaluating the management of intermittent claudication before and after publication of the Society of Vascular Surgery's Appropriate Use Criteria. J Vasc Surg. 2025. PMID: 39880293. doi:10.1016/j.jvs.2024.12.133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。